1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Treatment for Chronic Fatigue Syndrome developed from cancer drug Rituximab – Active Quote

October 25, 2011Monoclonal Anti-CD20 Antibodiesadmin

Treatment for Chronic Fatigue Syndrome developed from cancer drug Rituximab
Active Quote
Cancer drug Rituximab has been shown to successfully treat the symptoms of chronic fatigue syndrome (CFS), supporting the theory that CFS is an autoimmune disease. Around 250000 people in the UK suffer from chronic fatigue syndrome, also known as ...

and more »

Post navigation

← Organ donation should be mandatory. It's no good someone in a coffin…I miss … – Glasgow Evening Times SwedishAmerican establishes heart failure clinic with UW Health – WREX-TV →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos